Dyslipidemia poses a significant risk of many complications for Type 2 Diabetes Mellitus Patients: Article Review

Abstract

The most prevalent chronic illnesses to be identified and treated collectively are dyslipidemias. They are typically identified by triglycerides serum, cholesterol, or both, Atypical levels of related lipoprotein species, including high of very low density lipoproteins VLDL, low HDL cholesterol, high LDL cholesterol, and a predominance of small dense LDL particles, are also present. are all signs of diabetic dyslipidemia. Chronic Kidney disease (CKD) alone may result in dyslipidemia due to disruption of lipids metabolism. Hyperglycemia and insulin resistance may exacerbate dyslipidemia in diabetic patients with CKD. Patients with type 2 diabetes mellitus bear a disproportionately high burden of cardiovascular disease, the primary global origin of morbidity and mortality, with the proportion of CVD attributed to diabetes rising in the general population. A significant microvascular consequence of diabetes is diabetic retinopathy (DR). Among developed countries, it is the most frequent cause of blindness among people of working age. The most prevalent neuropathy, diabetic neuropathy, has a variety of clinical symptoms connected with it. After the age of 50, it typically occurs, and people with long-term diabetes mellitus are more likely to experience it. However, macrovascular pathogenesis is also involved. It begins with microvascular damage to the tiny blood arteries that nourish the nerves. The aim of writing this article is that the imbalance of fats and their high concentrations in the human body of a patient with type 2 diabetes generates many complications, which over time are dangerous complications that threaten the life of a diabetic patient and lead to his death if these complications are not controlled because the high levels of sugar and fat in the human body It plays an important role in the development of the patient's condition.